C12Y 302/01031
Beta-glucuronidase
Official title: Beta-glucuronidase (3.2.1.31)
C12Y302/01031 (Beta-glucuronidase) appears on 186 US grants and 216 published applications in this corpus.
Search patents in C12Y- Granted patents
- 186
- Published applications
- 216
- Assignees
- 146
- Inventors
- 432
- Latest grant
- 21 Apr 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1987 | 1 | 0 |
| 1988 | 1 | 0 |
| 1989 | 2 | 0 |
| 1990 | 1 | 0 |
| 1991 | 0 | 0 |
| 1992 | 0 | 0 |
| 1993 | 3 | 0 |
| 1994 | 3 | 0 |
| 1995 | 3 | 0 |
| 1996 | 3 | 0 |
| 1997 | 7 | 0 |
| 1998 | 7 | 0 |
| 1999 | 12 | 0 |
| 2000 | 4 | 0 |
| 2001 | 10 | 1 |
| 2002 | 11 | 7 |
| 2003 | 7 | 12 |
| 2004 | 5 | 13 |
| 2005 | 4 | 12 |
| 2006 | 8 | 4 |
| 2007 | 5 | 3 |
| 2008 | 2 | 6 |
| 2009 | 0 | 3 |
| 2010 | 0 | 7 |
| 2011 | 3 | 7 |
| 2012 | 7 | 8 |
| 2013 | 6 | 7 |
| 2014 | 5 | 4 |
| 2015 | 4 | 8 |
| 2016 | 6 | 10 |
| 2017 | 7 | 11 |
| 2018 | 4 | 11 |
| 2019 | 10 | 13 |
| 2020 | 7 | 8 |
| 2021 | 2 | 12 |
| 2022 | 5 | 8 |
| 2023 | 4 | 8 |
| 2024 | 8 | 11 |
| 2025 | 6 | 12 |
| 2026 | 3 | 10 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Proteins having pneumococcal capsule degrading activity and methods of use21 Apr 2026US 12,605,429 B2University of Georgia Research Foundation, Inc.
- Treatment of age-related cognitive decline using genetically modified viral vectors3 Mar 2026US 12,564,646 B2Bioviva USA Inc.
- Genetically modified mesenchymal stem cell expressing Klotho24 Feb 2026US 12,559,724 B2Apceth GmbH & Co. KG
- Cross-linking compounds and methods of use thereof23 Dec 2025US 12,502,440 B2North Carolina State University
- Plant regulatory elements and uses thereof30 Sep 2025US 12,428,647 B2Monsanto Technology LLC
- Klotho mrna10 Sep 2026US 2026/0265718 A1Advantage Therapeutics, Inc.
- Methods and materials for treating gastrointestinal disorders27 Aug 2026US 2026/0248863 A1Mayo Foundation for Medical Education and Research
- Stem cell reprogramming with gene-enhanced stem cells23 Jul 2026US 2026/0207672 A1
- Secreted splicing variant of klotho for extending lifespan16 Jul 2026US 2026/0199440 A1
- Increasing klotho levels2 Jul 2026US 2026/0183326 A1Advantage Therapeutics, Inc.
Most cited
By later US patents
- Plant viral vectors having heterologous subgenomic promoters for systemic expression of foreign genes185US 5,316,931 ABiosource Genetics Corporation · 1994
- Biocompatible implant for the expression and in vivo secretion of a therapeutic substance151US 5,906,817 AInstitut Pasteur · 1999
- Plant promoter .alpha.-glucuronidase gene construct146US 5,268,463 A1993
- Methods for obtaining modified phenotypes in plant cells122US 6,423,885 B1Commonwealth Scientific and Industrial Research Organization (CSIRO) · 2002
- Methods and vectors for site-specific recombination109US 5,801,030 AGenVec, Inc. · 1998